CRBN Corbion N.V.

28.12USD25.58 EUR · AMS0.00%Mkt Cap: 1.62B USDP/E: 24.13

Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the …

Institutional holders10 on file

Key Statistics

Company
Market Cap1.62B USD
Enterprise Value2.15B USD
Revenue (TTM)1.38B USD
Gross Profit363.07M USD
Net Income (TTM)82.22M USD
Revenue/Share23.86 USD
Last Price28.12 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.4K
CountryNL
SectorBasic Materials
IndustrySpecialty Chemicals
ISINNL0010583399
Valuation
P/E (Trailing)24.13
P/E (Forward)14.78
PEG1.26
EV/EBITDA11.53
EV/Revenue1.56
P/S1.18
P/B1.95
EPS (TTM)1.17 USD
EPS (Forward)1.90 USD
52W Range
18.9779% of range30.51
52W High30.51 USD
52W Low18.97 USD
Profitability
Gross Margin26.06%
Oper. Margin8.00%
EBITDA Margin13.54%
Profit Margin5.90%
ROE10.07%
ROA5.28%
ROIC8.02%
ROCE10.49%
Growth
Revenue Growth-2.20%
Earnings Growth-29.20%
Cash Flow & Leverage
Operating CF176.86M USD
CapEx (TTM)74.97M USD
FCF Margin-5.46%
FCF Yield-4.64%
Net Debt529.37M USD
Net Debt/EBITDA2.84
Net Debt/FCF—
Balance Sheet
Debt/Equity0.60
Current Ratio1.83
Quick Ratio0.90
Book Value/Sh14.41 USD
Cash/Share0.69 USD
Dividends
Fwd Div Rate0.70 USD
Trail. Div Rate0.70 USD
Div. Yield2.47%
5Y Avg Yield2.46%
Payout Ratio60.38%
Ex-Div DateMay 15, 2026
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.11 USD
Upside (mean)+10.6%
Target Range21.54 USD – 37.37 USD
21.54+10.6% to mean37.37
# Analysts7
Ownership
Shares Out.57.65M
Float57.34M
Insiders0.22%
Institutions85.47%
Technical
SMA 5026.50 (+6.1%)
SMA 20022.82 (+23.2%)
Beta0.86
S&P 52W Chg12.00%
Avg Vol (30d)170.73K
Avg Vol (10d)95.67K
Technical Indicators
RSI (14)50.0
MACD0.5829
MACD Signal0.8595
MACD Hist.-0.2766
BB Upper30.71 USD
BB Middle29.05 USD
BB Lower27.39 USD
BB Width11.42%
ATR (14)0.6786 USD
Vol Ratio (20d)0.61x

About Corbion (AMS: CRBN)

›

Corbion (AMS: CRBN) is listed on Euronext Amsterdam, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 2,363 employees.

The shares were at 25.58 EUR on 20 November 2026, up 37.5% over 52 weeks. Its 52-week range is 17.26 EUR to 27.76 EUR: the price is 7.9% below the high and 48.2% above the low.

At a market capitalisation of 1.47B EUR, it trades at 24.1 times trailing earnings and 14.8 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 29% for CRBN. It pays a dividend yielding 2.47% (it pays out 60% of its earnings), against a median of 1.76% among the dividend payers in that peer group.

Corbion reports return on equity of 10.1%, an operating margin of 8.0% and revenue down 2.2% year over year.

Its debt exceeds its cash by 481.60M EUR, a debt-to-equity ratio of 0.60. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 28.30 EUR is 10.6% above the current price. The next earnings report is expected on 26 February 2027.